169 related articles for article (PubMed ID: 32640956)
21. Effect of raloxifene on sexual function in postmenopausal women.
Kessel B; Nachtigall L; Plouffe L; Siddhanti S; Rosen A; Parsons A
Climacteric; 2003 Sep; 6(3):248-56. PubMed ID: 14567773
[TBL] [Abstract][Full Text] [Related]
22. Local oestrogen for vaginal atrophy in postmenopausal women.
Suckling J; Lethaby A; Kennedy R
Cochrane Database Syst Rev; 2006 Oct; (4):CD001500. PubMed ID: 17054136
[TBL] [Abstract][Full Text] [Related]
23. Systemic effects of conjugated equine estrogen vaginal cream on bone turnover markers in postmenopausal women.
Luengratsameerung S; Panyakhamlerd K; Treratanachat S; Taechakraichana N
Climacteric; 2013 Feb; 16(1):133-40. PubMed ID: 22515801
[TBL] [Abstract][Full Text] [Related]
24. A comparative study of vaginal estrogen cream and sustained-release estradiol vaginal tablet (Vagifem) in the treatment of atrophic vaginitis in Isfahan, Iran in 2010-2012.
Hosseinzadeh P; Ghahiri A; Daneshmand F; Ghasemi M
J Res Med Sci; 2015 Dec; 20(12):1160-5. PubMed ID: 26958050
[TBL] [Abstract][Full Text] [Related]
25. Twice-weekly synthetic conjugated estrogens vaginal cream for the treatment of vaginal atrophy.
Freedman M; Kaunitz AM; Reape KZ; Hait H; Shu H
Menopause; 2009; 16(4):735-41. PubMed ID: 19252451
[TBL] [Abstract][Full Text] [Related]
26. Treatment of atrophic vaginitis with topical conjugated equine estrogens in postmenopausal Asian women.
Raymundo N; Yu-cheng B; Zi-yan H; Lai CH; Leung K; Subramaniam R; Bin-rong C; Ling YS; Nasri N; Calimon N
Climacteric; 2004 Sep; 7(3):312-8. PubMed ID: 15669556
[TBL] [Abstract][Full Text] [Related]
27. A comparative study of safety and efficacy of continuous low dose oestradiol released from a vaginal ring compared with conjugated equine oestrogen vaginal cream in the treatment of postmenopausal urogenital atrophy.
Ayton RA; Darling GM; Murkies AL; Farrell EA; Weisberg E; Selinus I; Fraser ID
Br J Obstet Gynaecol; 1996 Apr; 103(4):351-8. PubMed ID: 8605133
[TBL] [Abstract][Full Text] [Related]
28. Resistance and barriers to local estrogen therapy in women with atrophic vaginitis.
Kingsberg SA; Krychman ML
J Sex Med; 2013 Jun; 10(6):1567-74. PubMed ID: 23534861
[TBL] [Abstract][Full Text] [Related]
29. Vaginal estrogens for the treatment of dyspareunia.
Krychman ML
J Sex Med; 2011 Mar; 8(3):666-74. PubMed ID: 21091878
[TBL] [Abstract][Full Text] [Related]
30. Atrophic vaginitis.
Stika CS
Dermatol Ther; 2010; 23(5):514-22. PubMed ID: 20868405
[TBL] [Abstract][Full Text] [Related]
31. Effects of preoperative local estrogen in postmenopausal women with prolapse: a randomized trial.
Rahn DD; Good MM; Roshanravan SM; Shi H; Schaffer JI; Singh RJ; Word RA
J Clin Endocrinol Metab; 2014 Oct; 99(10):3728-36. PubMed ID: 24947034
[TBL] [Abstract][Full Text] [Related]
32. Effects of low dose estrogen therapy on the vaginal microbiomes of women with atrophic vaginitis.
Shen J; Song N; Williams CJ; Brown CJ; Yan Z; Xu C; Forney LJ
Sci Rep; 2016 Apr; 6():24380. PubMed ID: 27103314
[TBL] [Abstract][Full Text] [Related]
33. Local oestrogen for vaginal atrophy in postmenopausal women.
Suckling J; Lethaby A; Kennedy R
Cochrane Database Syst Rev; 2003; (4):CD001500. PubMed ID: 14583935
[TBL] [Abstract][Full Text] [Related]
34. Conjugated estrogens (Premarin) vaginal cream.
Med Lett Drugs Ther; 2009 Feb; 51(1306):14-5. PubMed ID: 19229162
[TBL] [Abstract][Full Text] [Related]
35. Low-dose 17-β-estradiol cream for vaginal atrophy in a cohort without prolapse: Serum levels and vaginal response including tissue biomarkers associated with tissue remodeling.
Illston JD; Wheeler TL; Parker CR; Conner MG; Burgio KL; Goode PS; Richter HE
Maturitas; 2015 Aug; 81(4):475-9. PubMed ID: 26115591
[TBL] [Abstract][Full Text] [Related]
36. Vaginal ultrasound of the endometrium in postmenopausal women with symptoms of urogenital atrophy on low-dose estrogen or tibolone treatment: a comparison.
Botsis D; Kassanos D; Kalogirou D; Antoniou G; Vitoratos N; Karakitsos P
Maturitas; 1997 Jan; 26(1):57-62. PubMed ID: 9032748
[TBL] [Abstract][Full Text] [Related]
37. Effect of Trigonella foenum (fenugreek) vaginal cream on vaginal atrophy in postmenopausal women.
Mazalzadeh F; Hekmat K; Namjouyan F; Saki A
J Family Med Prim Care; 2020 Jun; 9(6):2714-2719. PubMed ID: 32984113
[TBL] [Abstract][Full Text] [Related]
38. Vaginal estrogen for genitourinary syndrome of menopause: a systematic review.
Rahn DD; Carberry C; Sanses TV; Mamik MM; Ward RM; Meriwether KV; Olivera CK; Abed H; Balk EM; Murphy M;
Obstet Gynecol; 2014 Dec; 124(6):1147-1156. PubMed ID: 25415166
[TBL] [Abstract][Full Text] [Related]
39. The effect of nettle vaginal cream on subjective symptoms of vaginal atrophy in postmenopausal women.
Karimi FZ; Nazari N; Rakhshandeh H; Mazloum SR
Eur J Obstet Gynecol Reprod Biol; 2023 Jun; 285():41-45. PubMed ID: 37044017
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]